The VA Medication Rule (RIN 2900-AS49): What Happened, and Where Your Rating Stands Now

A VA rule that would have let medication lower some disability ratings took effect in February 2026 and was pulled days later. Here is the current standard and what is still worth watching.

Current status - last verified June 5, 2026: Rescinded. The February 2026 VA medication-rating interim final rule (RIN 2900-AS49) was rescinded on February 27, 2026. Ratings are once again evaluated under the prior 38 CFR § 4.10 standard and the Ingram v. Collins framework for the medication issue it addressed. VA's Federal Circuit appeal was dismissed on March 30, 2026, so do not treat that appeal as pending.

What the rule would have done

On February 17, 2026, VA published an interim final rule amending 38 CFR § 4.10, the regulation governing how functional impairment is evaluated. The rule directed examiners not to discount the effects of medication or treatment, meaning a veteran could be rated on how they function while medicated rather than on the underlying impairment.

That change could have affected ratings across body systems, including musculoskeletal, cardiovascular, digestive, and mental-health conditions. In practice, it could have lowered ratings for veterans whose symptoms are partially controlled by medication.

The February timeline

• February 17, 2026: VA published the interim final rule, "Evaluative Rating: Impact of Medication" (RIN 2900-AS49), effective immediately.
• February 19, 2026: After heavy pushback from veterans and veterans' groups, VA announced the rule would not be enforced.
• February 27, 2026: VA formally rescinded the rule and restored the prior regulatory text.
• March 30, 2026: The Federal Circuit dismissed VA's appeal in Ingram v. Collins after the parties agreed to dismissal.

The practical bottom line: the February medication rule is dead. Veterans should not rely on it, cite it as active, or plan around any expired comment process for it.

What Ingram Means Now

Ingram v. Collins concerned whether VA could give a lower rating by relying on the beneficial effects of medication when the applicable rating criteria do not account for those effects. With the interim rule rescinded and the Federal Circuit appeal dismissed, the Ingram framework is back in effect for the issue it addressed.

That does not mean every condition, diagnostic code, or fact pattern is handled the same way. Some rating criteria expressly mention medication or treatment. Others do not. The safe move is to focus on the exact diagnostic code, medical facts, and evidence in your own record.

What this means for your claim right now

The pre-February standard is back. Your rating is evaluated based on functional impairment under the current rating criteria, and being "controlled on medication" does not automatically mean "no impairment."

If you had a claim, proposal, or exam during the brief February window and medication effects appear central to the outcome, it is worth a second look with qualified help.

Look for:

• The diagnostic code VA used
• Whether that code expressly contemplates medication or treatment
• The C&P exam language about medication, treatment, flare-ups, and ordinary activity
• The decision's reasons and bases
• Any deadline for a supplemental claim, higher-level review, Board appeal, or response to a proposal

What is still worth watching

The appeal is no longer pending, but the regulatory issue is still worth monitoring. VA could try future rulemaking if it wants a different medication-rating standard. If that happens, the important questions will be the proposed text, the comment period, the effective date, and whether the final rule changes the rating schedule or preserves the current Ingram framework.

We will update this page if the standard changes.

What to do

• Make sure your medical records document functional impairment, even when symptoms are managed with medication.
• Track medication side effects; they can matter when they affect work, sleep, mobility, concentration, digestion, or daily activity.
• Keep records showing dosage changes, breakthrough symptoms, flare-ups, missed work, urgent visits, therapy notes, and assistive devices.
• Do not go off prescribed medication to "look worse" for an exam. That is dangerous and unnecessary.
• If you are unsure how a rule change affects your specific case, talk to a VA-accredited representative, VSO, claims agent, or attorney.

How ValorAI can help

• Build a medication and symptoms timeline
• Turn side effects, flare-ups, and breakthrough symptoms into organized evidence notes
• Draft questions to ask an accredited representative or clinician
• Compare your rating decision against the diagnostic code and cited evidence
• Prepare a non-legal summary for VSO, claims-agent, attorney, or clinician review

ValorAI provides general information, not legal advice, and is not a VA-accredited representative.

Bottom line

The February 2026 medication rule should no longer be described as active. VA rescinded it on February 27, 2026, restored the prior regulatory text, and the Federal Circuit dismissed VA's Ingram appeal on March 30, 2026.

Official Sources

• Federal Register: Rescission of Interim Final Rule, Evaluative Rating: Impact of Medication
• GAO: Department of Veterans Affairs, Rescission of Interim Final Rule
• Federal Circuit Order: Ingram v. Collins, No. 25-1972
• NVLSP: VA Cannot Award A Lower Rating Based On Ameliorative Medication Effects

This article is for informational purposes and is not legal advice.